Non ci sono recensioni
Evolving Role of CRS and HIPEC: Current Indications
Pages 3-14
The widespread acceptance among the oncology community at large of cytoreductive surgery and HIPEC as a potentially curative treatment for peritoneal metastases has paved the way for innovative new therapies that could benefit a larger proportion of patients. Much has been and continues to be published on this subject.
This book provides comprehensive reviews on the various aspects of managing peritoneal metastases. The authors highlight essential practical issues that surgical oncologists encounter in their day-to-day practice, and try to before provide evidence based answers to address them. All chapters were written and/or reviewed by leading experts in this field.
Evolving Role of CRS and HIPEC: Current Indications
Pages 3-14
Role of HIPEC in the Prevention of Peritoneal Metastasis from Colorectal, Gastric and Appendiceal Cancer
Pages 15-30
Cytoreductive Surgery for Peritoneal Metastases: Principles and Techniques
Pages 31-77
HIPEC Methodology, Comparison of Techniques, and Drug Regimens: Is There a Need for Standardization?
Pages 79-102
Early Postoperative Intraperitoneal Chemotherapy: Current Role and Future Perspectives
Pages 103-133
Imaging of Peritoneal Cancers
Pages 135-145
Diagnostic Laparoscopy for the Evaluation of Peritoneal Metastases
Pages 147-160
Combined Resection Liver Metastases and Peritoneal Metastases
Pages 161-179
Management of Complications of CRS and HIPEC
Pages 181-217
Cytoreductive Surgery and Intraperitoneal Chemotherapy for Advanced Epithelial Ovarian Cancer
Pages 221-252
Surgical Management of Recurrent Epithelial Ovarian Cancer
Pages 253-280
Multimodality Treatment for Colorectal Peritoneal Metastases
Pages 281-316
Pseudomyxoma Peritonei Arising from Epithelial Appendiceal Tumours
Pages 317-346
Intraperitoneal Chemotherapy for Gastric Cancer
Pages 347-359
Malignant Peritoneal Mesothelioma
Pages 361-368
Rare Indications for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Pages 369-432
Clinical Trials in CRS and HIPEC: Ongoing Trials and Future Directives
Pages 433-445
Cytoreductive Surgery and HIPEC in the Elderly
Pages 449-459
Quality of Life Issues in Patients Undergoing Cytoreductive Surgery and HIPEC
Pages 461-467
New Treatment Modalities for the Management of Peritoneal Metastases
Pages 469-506
Registries and Collaborative Groups in Peritoneal Surface Oncology
Pages 507-526
Locoregional and Palliative Therapies for Patients with Unresectable Peritoneal Metastases
Pages 527-559
Training Programs for Cytoreductive Surgery and HIPEC
Pages 561-568
Sei sicuro di voler eseguire questa azione?